Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease M Bohm, R Xu, Y Zhang, S Varma, M Fischer, G Kochhar, B Boland, ... Alimentary Pharmacology & Therapeutics 52 (4), 669-681, 2020 | 60 | 2020 |
Comparative safety and effectiveness of vedolizumab to tumor necrosis factor antagonist therapy for ulcerative colitis D Lukin, D Faleck, R Xu, Y Zhang, A Weiss, S Aniwan, S Kadire, G Tran, ... Clinical Gastroenterology and Hepatology 20 (1), 126-135, 2022 | 46 | 2022 |
Prevalence and severity of sleep disturbances among patients with early breast cancer R Fakih, M Rahal, L Hilal, L Hamieh, M Dany, S Karam, L Shehab, ... Indian journal of palliative care 24 (1), 35, 2018 | 44 | 2018 |
A comparative study of 22G versus 19G needles for EUS-guided biopsies for parenchymal liver disease: are thinner needles better? HK Patel, R Saxena, N Rush, SK Patel, CS Dasari, W Mneimneh, ... Digestive Diseases and Sciences 66, 238-246, 2021 | 33 | 2021 |
Preoperative biliary drainage for malignant biliary obstruction: results from a national database Y Shaib, MA Rahal, MO Rammal, A Mailhac, H Tamim Journal of Hepato‐Biliary‐Pancreatic Sciences 24 (11), 637-642, 2017 | 33 | 2017 |
Intragastric balloon treatment of obesity: Long-term results and patient satisfaction A El Haddad, MO Rammal, A Soweid, AI Sharara, F Daniel, MA Rahal, ... The Turkish Journal of Gastroenterology 30 (5), 461, 2019 | 29 | 2019 |
CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates RJ Rachwan, I Kutkut, LR Timsina, RGB Chaaya, EA El-Am, M Sabra, ... Journal of hepatology 75 (1), 142-149, 2021 | 28 | 2021 |
COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND TUMOR NECROSIS FACTOR-ANTAGONIST THERAPY IN CROHN'S DISEASE: A MULTICENTER CONSORTIUM PROPENSITY SCORE-MATCHED ANALYSIS M Bohm, S Sagi, M Fischer, S Kadire, G Tran, M Rahal, S Aniwan, ... Gastroenterology 154 (6), S369-S370, 2018 | 27* | 2018 |
OP026 Comparative effectiveness of vedolizumab and TNF-antagonist therapy in ulcerative colitis: a multicentre consortium propensity score-matched analysis D Faleck, P Shashi, J Meserve, M Rahal, S Kadire, G Tran, A Weiss, ... Journal of Crohn's and Colitis 12 (supplement_1), S019-S019, 2018 | 19 | 2018 |
Predictors of bile tree pathology in patients presenting with gallbladder disease MA Rahal, MO Rammal, W Karaoui, A Hallal, H Tamim, Y Shaib European Journal of Gastroenterology & Hepatology 29 (9), 1017-1021, 2017 | 17 | 2017 |
The natural history of incidental colonic diverticulosis on screening colonoscopy AI Sharara, N Ziade, RH Shayto, LBO Rustom, H Chehab, HH Rimmani, ... Canadian Journal of Gastroenterology and Hepatology 2018 (1), 3690202, 2018 | 15 | 2018 |
DOP009 Comparative safety profile of vedolizumab and tumour necrosis factor–antagonist therapy for inflammatory bowel disease: a multicentre consortium propensity score-matched … D Lukin, A Weiss, S Aniwan, S Kadire, G Tran, M Rahal, D Faleck, ... Journal of Crohn's and Colitis 12 (supplement_1), S036-S036, 2018 | 14* | 2018 |
277-Comparative safety profile of vedolizumab and tumor necrosis factor-antagonist therapy for inflammatory bowel disease: A multicenter consortium propensity score-matched … DJ Lukin, A Weiss, S Aniwan, S Kadire, G Tran, M Rahal, D Faleck, ... Gastroenterology 6 (154), S-68, 2018 | 12 | 2018 |
Surgical outcomes among inflammatory bowel disease patients undergoing colectomy: results from a national database. MA Rahal, WR Karaoui, A Mailhac, H Tamim, Y Shaib Acta gastro-enterologica Belgica 81 (3), 387-392, 2018 | 9 | 2018 |
Increased rebleeding and mortality in patients with gastrointestinal bleeding treated with anticoagulant drugs compared to antiplatelet drugs M Hosni, M Rahal, H Tamim, F Daniel, J Al Hashash, AI Sharara, ... European Journal of Gastroenterology & Hepatology 33 (1S), e490-e498, 2021 | 8 | 2021 |
328-Comparative Effectiveness of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy in Ulcerative Colitis: A Multicenter Consortium Propensity Score-Matched Analysis D Faleck, P Shashi, J Meserve, M Rahal, S Kadire, G Tran, A Weiss, ... Gastroenterology 6 (154), S-82, 2018 | 7 | 2018 |
Serial EUS-guided FNA for the surveillance of pancreatic cysts: A study of long-term performance of tumor markers MA Rahal, JM DeWitt, H Patel, CM Schmidt, EP Ceppa, RE Simpson, ... Digestive diseases and sciences 67 (11), 5248-5255, 2022 | 6 | 2022 |
An exclusive fine-needle biopsy approach to sampling solid lesions under EUS guidance: a prospective cohort study LM Temnykh, MA Rahal, Z Zia, MA Al-Haddad Gastroenterology Report 8 (5), 349-354, 2020 | 5 | 2020 |
Endoscopic ultrasound-guided sampling of solid pancreatic lesions: a comparative analysis of 25 gauge versus 22 gauge core biopsy needles DA Siddique, MA Rahal, K Trevino, HH Wu, MA Al-Haddad Anticancer Research 40 (10), 5845-5851, 2020 | 5 | 2020 |
The clinical significance of incidental GIT uptake on PET/CT: radiologic, endoscopic, and pathologic correlation MN Hosni, M Kassas, MI Itani, MA Rahal, S Al-Zakleet, M El-Jebai, ... Diagnostics 13 (7), 1297, 2023 | 2 | 2023 |